When the Lord smote the Philistines with emerods in their secret parts he left it to historians to debate the nature of this lethal affliction. Literally translated, emerods are haemorrhoids, but it is surely unlikely that so hardy a race would have succumbed to an epidemic of piles. Scholarly opinion seems to concur that the emerods were buboes in the groin, one of the agonising manifestations of the plague. So the disease, it seems, has been with us for millenia, but since the last major outbreak in 1894, which carried off 12 million of its victims, has -or so it was thought until a few years ago -yielded to antibiotics. Now the Black Death, it seems, has returned, and most recently in antibiotic-resistant form. More, as a past leader of the Soviet biological weapons programme, Colonel Kanatjan Alibekov (now Ken Alibek and an American citizen) has disclosed, strains carrying plasmids for resistance to a range of antibiotics, and for good measure a gene expressing a neurotoxin, were developed in Russia and stockpiled in twentyton quantities. Yersinia pestis, Alibek averred, is easily 'weaponized', and pneumonic plague, the most virulent form, is conveniently disseminated on the breath of expiring victims.
become a familiar spectre in the hospitals of the West. It is thought to kill annually some 28 million people around the world.
The theme of Shnayerson and Plotkin's scrupulously researched and mesmerising book is the infinite capacity of bacteria to mutate and neutralise all missiles that science has thrown at them, and the human folly and rapacity that has allowed them full scope.
The theme ... is the infinite capacity of bacteria to mutate and neutralise all missiles that science has thrown at them and the human folly and rapacity that has allowed them full scope. These were the oxazolidinones and a group of quinolone derivatives. The oxazolidinones, bacteriostatic rather than bactericidal, were expensive: it had cost Rhone-Poulenc Rorer $0.5 billion to bring Synercid to the market, and this outlay was reflected in the cost of treatment -up to $250 a day. It was agreed that neither the oxazolidinones nor the quinolones, licensed for human use, would be given to animals, but before long the agricultural industry had got its hands on analogues of both, either for growth-enhancement or for therapy.
Before long animals around the world were found to be abundantly infested with pathogens, with Salmonella or Campylobacter. (The egregious UK agriculture minister, Edwina Curry, lost her job for uttering the unpalatable truth.)
In the US consumer groups and the Center for Disease Control, which had for years been campaigning ceaselessly against indiscriminate use of antibiotics, demanded the withdrawal of quinolones from agriculture. As ever, the powerful agricultural lobby lied and intrigued to protect profits.
The story of the antibiotics is a melancholy litany of folly and greed. Human nature will not be gainsaid. As Kipling has it, There are only four things certain since Social Progress beganThat the Dog returns to his vomit and the Sow returns to her Mire, And the burnt Fool's bandaged finger goes wabbling back to the Fire … Attempts to find new antibiotic substances are not now, it seems, a matter of high priority for Big Pharma. The cost of bringing drugs to market has risen alarmingly, and it is medication for chronic maladies, rather than single-shot cures for infections, that will sustain the profits.
Tuberculosis is still to a large extent a disease of destitute populations, though that is beginning to change. The focus, Shnayerson and Plotkin reveal, has in large measure shifted to vaccines, assisted by genomic strategies and improved procedures for rapid identification of the agents of infection. And perhaps the whole notion of eliminating the wily pathogens once and for all was misconceived: might it not be better to treat infections conservatively, for then the evolutionary advantage will rest with more benign strains, which do not kill their hosts?
There is also now much research on peptides to inhibit the binding of the pathogen to its cell receptors. These have been sought in such improbable hiding-places as the saliva of the Komodo dragon. Finally, the longneglected possibilities of bacteriophages are once more being taken seriously.
It was a revelation to me that these specialised viruses have been in therapeutic use in the countries of the former Soviet imperium ever since their discovery nearly a century ago, or that they reputedly saved untold numbers of lives on the battlefields of the Second World War. Research into phage therapy has somehow continued in the decayed and impoverished laboratories of Eastern Europe, most notably the Eliava Institute in ravaged Tbilisi.
Perhaps, paradoxically, it is the shadow of Al Qaeda and those elusive envelopes of anthrax bacilli that will now liberate the money and talent needed to combat the depredations of man's ancient unicellular enemies.
All this and more you will learn from The Killers Within, which serves at once as a wholly absorbing tale of scientific detection, a lesson in biology, a tableau of grand guignol and a powerful admonition on the misuse of science. Read, learn and ponder. 
